PRA’s remote patient monitoring platform selected by Merck KGaA, Darmstadt, Germany to work in combination with its human growth hormone treatment system

RALEIGH, N.C. , April 07, 2021 (GLOBE NEWSWIRE) — PRA Health Sciences (NASDAQ: PRAH) announced today that Merck KGaA, Darmstadt, Germany, known in the United States as EMD Serono, selected PRA's remote patient monitoring platform to work in combination with its human growth hormone (HGH) treatment system. Under this agreement, PRA's remote patient monitoring platform backs Merck KGaA, Darmstadt, Germany's HGH treatment system, including growlinkTM, a mobile app for patients prescribed with HGH treatment, and easypod Connect, a secure platform for healthcare professionals (HCP) in the field of endocrinology to monitor patients' adherence, review injection history, and share information about patients' progression with growth hormone disorder.

"Patients and payers expect us to offer new technologies, such as treatment–supporting apps, with the highest levels of privacy and data security," said Andre Musto, Senior Vice President and Head of Cardiovascular Metabolism & Endocrinology, Merck KGaA, Darmstadt, Germany. "With growlink and easypod Connect, supported by PRA's remote patient monitoring platform, we can offer patients innovative tools to help manage their condition and assure payers of the effective use of treatments while fully respecting their privacy and data security."

Human growth hormone treatments are frequently prescribed for children and adolescents with growth hormone deficiency, a condition that impacts approximately 1:4,000 to 1:10,000 children1 each year in the U.S. Despite the prevalence of growth hormone deficiency and treatment options, one of the biggest challenges is ensuring patients' adherence to the regimen. Adding this layer of technology to HGH treatments better facilitates patient engagement, helps HCPs make better use of patient visits, and ensures the treatment is taken regularly and at the right dosage, optimizing treatment outcome and driving payer confidence.

In a real–world setting, an HCP would use easypod Connect to invite patients to download the mobile app, growlink. Then the patient downloads the mobile app, signs an eConsent form on the app, and syncs the app with Merck KGaA, Darmstadt, Germany's HGH injector medical device, easypod. This device is able to self–regulate the appropriate dosage of HGH based on the treatment protocol. The four–part system "" Merck KGaA, Darmstadt, Germany's mobile app (growlink), connected device (easypod), and HCP platform (easypod Connect ) underpinned by PRA's remote patient monitoring technology "" enables HCPs to see an accurate picture of patients' adherence, height, weight, and other outcomes while offering patients a more convenient way to follow to their treatment regimen and manage their condition.

"For many years, PRA has been focused on designing an end–to–end digital health platform that supports mobile healthcare delivery, such as remote patient monitoring," said Kent Thoelke, Executive Vice President and Chief Scientific Officer, PRA Health Sciences. "Our collaboration with Merck KGaA, Darmstadt, Germany to support growlink and easypod Connect is an example of how the industry is advancing with the patient at the center of our innovation."

PRA hosted a webinar called, How Digital Therapeutics and Remote Patient Monitoring Can Drive Pharmaceutical Product Differentiation, to help create differentiation. Access the replay webinar today.

For more information about PRA's remote patient monitoring solutions, visit

1 Stanley T. Diagnosis of Growth Hormone Deficiency in Childhood. HHS Public Access. Available at

About PRA Health Sciences

PRA Health Sciences is one of the world's leading global contract research organizations by revenue, providing outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries. PRA's global clinical development platform includes more than 75 offices across North America, Europe, Asia, Latin America, Africa, Australia and the Middle East and more than 19,000 employees worldwide. Since 2000, PRA has participated in approximately 4,000 clinical trials worldwide. In addition, PRA has participated in the pivotal or supportive trials that led to U.S. Food and Drug Administration or international regulatory approval of more than 95 drugs. To learn more about PRA, please visit


MEDIA INQUIRIES: Laurie Hurst, Sr. Director, Communications and Public Relations | +1 (919) 786–8435

Leave a Reply

RSS Daily Times Nigeria

  • IPOB alleges eastern Governors, Ohanaeze Ndigbo and others are compiling their names
    Indigenous People of Biafra (IPOB), a Nigerian separatist group, has claimed that the governors of the Eastern region, as well as the Igbo apex socio-cultural organization, Ohanaeze Ndigbo, and others, are compiling a list of its members, including members of the Eastern Security Network, with the intention of handing it over to the APC-led Federal […]
  • Bishop Oyedepo: “I hope there is no agenda to deplete the population of this nation”
    Bishop David Oyedepo is the founder and presiding Bishop of the megachurch Faith Tabernacle in Ota, Ogun State, Nigeria, and Living Faith Church Worldwide, also known as Winners’ Chapel International. He is a Nigerian preacher, Christian author, businessman, and architect. He responds to the news that some company told their workers that if they didn’t […]
  • Damasak: Nigerian Soldiers Overpower ISWAP Top Commander, Others
    Boko Haram senior commander Bukar Gana and scores of revenge fighters were killed on Thursday in Damasak, Borno State. After a week-long air and ground campaign in Mobbar Local Government Area, 12 high-value ISWAP commanders were neutralized. It’s also worth noting that Damasak has been attacked before and has always struggled. Despite the sinister activities […]
  • Chelsea 1-0 Man City: Hakim Ziyech’s goal puts Blues into FA Cup final
    Chelsea ended Manchester City’s quadruple bid as Hakim Ziyech’s goal secured a 1-0 win at Wembley to send Thomas Tuchel’s side through to the FA Cup final. Ziyech converted Timo Werner’s squared pass after Chelsea sprang the Manchester City offside trap 10 minutes into the second half and the goal proved decisive in a game […]

Weather for Abuja


RSS Vanguard News

  • Oil Spill: Don’t engage in ethnic conflict Rep member, Ereyitomi cautions Ijaw, Itsekiri youths
    The Member Representing Warri Federal Constituency in the House of Representatives, Hon. Thomas Ereyitomi, has cautioned Gbaramatu Ijaw Youths and their Itsekiri neighbours not to engage in ethnic conflict because of crude oil spill that occurred at Chevron’s Abiteye and Utonana Fields in Delta State.  The  lawmaker, who acknowledged that agitations for a proper JIVRead […]
  • Alleged N69bn fraud: Olejeme’s return to face EFCC charges has vindicated me – Ubani 
    By Henry Ojelu Former 2nd Vice-President of Nigerian Bar Association, NBA, Mr Monday Ubani has said that the return of the former Chairman of Nigerian Social Insurance Trust Fund, NSITF, Mrs Ngozi Olejeme to the country to face allegations of N69billion fraud by the Economic and Financial Crimes Commission EFCC has vindicated him of anyRead […]
  • Controversial terrorist comment: I’m now mature, know better, Pantami says
    As the controversy over affiliation with terrorist groups continues to mount, Minister of Communications and Digital Economy, Isa Pantami, has renounced his past comments. Pantami stated that for over a decade, he took the crusade on dangers of terrorism across major parts of the north, adding that he converted many young persons who have derailedRead […]

© 2021 Nigeria Newsline. All Rights Reserved. Log in -